ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "meta-analysis"

  • Abstract Number: 2475 • 2015 ACR/ARHP Annual Meeting

    Association Between Fibromyalgia and Suicidal Risk: A Systematic Review and Meta-Analysis

    Sikarin Upala1 and Anawin Sanguankeo2, 1Internal Medicine, Bassett Medical Center, Cooperstown, NY, 2Bassett Medical Center, Cooperstown, NY

    Background/Purpose: Chronic pain conditions are related poor overall health, economic burden, and mental disorders including suicidal ideation (SI), suicide attempts (SA), and completed suicides. Fibromyalgia…
  • Abstract Number: 2858 • 2015 ACR/ARHP Annual Meeting

    A Phosphodiesterase 4 Inhibitor for Psoriatic Arthritis: Systematic Review and Meta-Analysis

    Ignacio-Alfredo Valerio-Morales1, Maria A. Lopez-Olivo2, Xin Pan3 and Maria E. Suarez-Almazor4, 1Rheumatology, National Institute of Rehablitation, Mexico, Mexico, 2Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3Department of Rheumatology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, 4General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Inhibition of phosphodiesterase (PDE) family enzymes is now recognized as target to develop new psoriatic arthritis (PsA) drugs. We conducted a systematic review to…
  • Abstract Number: 2873 • 2015 ACR/ARHP Annual Meeting

    Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the EULAR Recommendations for the Management of PSA

    Sofia Ramiro1, Josef S. Smolen2, Robert B.M. Landewé3, Désirée van der Heijde1, Maxime Dougados4, Paul Emery5, Maarten de Wit6, Maurizio Cutolo7, Susan Oliver8 and Laure Gossec9, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 3Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 4Rheumatology Department, Cochin hospital, Paris-Descartes University, Paris, France, 5Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom, 6EULAR Social Leagues, Zurich, Switzerland, 7Division of Clinical Immunology, Dept Internal Medicine, University of Genova, Genova, Italy, 8Independent Nurse Consultant, North Devon, United Kingdom, 9Rheumatology, Pitié Salpetriere Hospital, Paris, France

    Background/Purpose: As part of the update of the EULAR recommendations for the management of PsA, we performed a systematic literature review to assess the efficacy…
  • Abstract Number: 2908 • 2015 ACR/ARHP Annual Meeting

    Diagnostic and Screening Accuracy of Spot Urinary Protein-Creatinine Ratio Compared to Protein Content in a 24 Hour-Urine Collection in Systemic Lupus Erythematosus: Systematic Review and Meta-Analysis

    Jorge Medina-Rosas1, Kristy Yap2, Melanie Anderson3, Jiandong Su2 and Zahi Touma2, 1Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Library and Information Services, University Health Network, University Health Network, Toronto, ON, Canada

    Background/Purpose: To systematically review literature on the utility of spot urinary protein-creatinine ratio (PCR) as a screening test for proteinuria and its ability to accurately…
  • Abstract Number: 673 • 2014 ACR/ARHP Annual Meeting

    A Comparison of Rheumatoid Arthritis and Systemic Lupus Erythematosus Trial Design: Ways to Improve Positive Trials in Systemic Lupus Erythematosus

    Amy Miles1 and Janet E. Pope2, 1Medicine, University of Western Ontario and U of Toronto, London, ON, Canada, 2St Joseph Health Care, London, ON, Canada

    Background/Purpose: Recent SLE RCTs were examined and compared to rheumatoid arthritis (RA) RCT to suggest modifications to SLE RCTs that could improve the future success…
  • Abstract Number: 477 • 2014 ACR/ARHP Annual Meeting

    Leflunomide Use Is Not Associated with an Increased Risk of Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomised Controlled Trials

    Richard Conway1, Candice Low2, Robert J. Coughlan1, Martin O'Donnell3 and John J. Carey1, 1Rheumatology, Galway University Hospitals, Galway, Ireland, 2Medicine, St. James Hospital, Dublin, Ireland, 3Clinical Research Facility, Galway University Hospitals, Galway, Ireland

    Background/Purpose Leflunomide is an effective treatment for rheumatoid arthritis. An association between pulmonary adverse events, in particular interstitial lung disease, and leflunomide use has been…
  • Abstract Number: 2772 • 2014 ACR/ARHP Annual Meeting

    The Use of Imaging in the Diagnosis of Polymyalgia Rheumatica: Systematic Literature Review and Meta-Analysis

    Sarah Mackie1, Gouri Koduri2, Catherine L. Hill3,4, Andrew Hutchings5, Richard J. Wakefield6, Bhaskar Dasgupta7 and Jeremy Wyatt8, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 2Rheumatology, York Teaching Hospital NHS Foundation Trust, York, United Kingdom, 3Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, 4Discipline of Medicine, University of Adelaide, Adelaide, Australia, 5Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, 6NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Department of Rheumatology, Southend University Hospital, Essex, United Kingdom, 8Leeds Insitute of Health Sciences, University of Leeds, Leeds, United Kingdom

    Background/Purpose ACR/EULAR provisional classification criteria for polymyalgia rheumatica (PMR) incorporate musculoskeletal ultrasound of shoulder and hip (bursitis and synovitis given equal weight). Our objective was…
  • Abstract Number: 2537 • 2014 ACR/ARHP Annual Meeting

    Diagnostic Accuracies of Sialography and Salivary Ultrasonography in Sjogren’s Syndrome Patients: A Meta-Analysis

    Young Ho Lee1 and Gwan Gyu Song2, 1Internal Medicine, Rheumatology, Korea University Medical Center, Seoul, South Korea, 2Div of Rheum, Dept of Int Medicine, Guro Hospital, Korea Univ College of Medicine, Seoul, South Korea

    Background/Purpose Ultrasonography (US) may come to replace conventional invasive examinations in clinical practice. However, the diagnostic accuracy of salivary US has not been clearly compared…
  • Abstract Number: 2501 • 2014 ACR/ARHP Annual Meeting

    Indirect Comparison of Tocilizumab and Tofacitinib in Patients with Rheumatoid Arthritis

    Stacey Chang1, Laura Sawyer1 and Fred Dejonckheere2, 1Symmetron Limited, London, United Kingdom, 2F. Hoffmann-La Roche, Basel, Switzerland

    Background/Purpose: Tocilizumab (TCZ) is a recombinant, humanized, monoclonal antibody directed against the cytokine interleukin-6 receptor, and tofacitinib (Tofa) is an oral, synthetic, disease-modifying antirheumatic drug…
  • Abstract Number: 2433 • 2014 ACR/ARHP Annual Meeting

    Efficacy of Ketoprofen Vs Ibuprofen and Diclofenac for Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

    Fabiola Atzeni1,2, Alessandra Monguzzi3, Elisabetta Grillo3, Luigi Lanata3 and Piercarlo Sarzi-Puttini2, 1V Giovanni Battista Grassi 74, Rheumatology Unit, L. Sacco University Hospital, Milan, Italy, 2Rheumatology Unit, L. Sacco University Hospital, Milan, Italy, 3Medical Department, Dompé SpA, Milan, Italy

    Background/Purpose: Patients with rheumatic diseases, including rheumatoid arthritis (RA), describe symptoms such as pain and stiffness as important factors affecting their quality of life. The…
  • Abstract Number: 2443 • 2014 ACR/ARHP Annual Meeting

    A New Meta-Analysis on Safety of Ketoprofen Vs Ibuprofen and Diclofenac: Risk and Benefit of Nsaids Beyond Efficacy Meta-Analysis

    P. Sarzi-Puttini1, F. Atzeni1, Luigi Lanata2, Alessandra Monguzzi2 and Michela Bagnasco2, 1Rheumatology Unit, L. Sacco University Hospital of Milan, Milan, Italy, 2Medical Department, Dompé SpA, Milan, Italy

    Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for management of mild-to-moderate pain, chronic inflammatory and degenerative joint diseases. Among NSAIDs, ketoprofen, ibuprofen and diclofenac…
  • Abstract Number: 2420 • 2014 ACR/ARHP Annual Meeting

    Quality Assessment of Controlled Trials Evaluating Chinese Herbal Medicine in Patients with Rheumatoid Arthritis:  a Systematic Review

    Xin Pan1,2, Maria A. Lopez-Olivo2, Pratibha Nayak3 and Maria E. Suarez-Almazor4, 1Department of Rheumatology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, 2Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 4The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Chinese herbal medicine (CHM) is a mainstay in the treatment of rheumatoid arthritis (RA) in China. We conducted a systematic review to appraise the…
  • Abstract Number: 2369 • 2014 ACR/ARHP Annual Meeting

    Management of Perioperative Tumor Necrosis -á Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis

    Susan M. Goodman1, Indu Menon2, Rie Smethurst3, Paul Christos4 and Vivian P. Bykerk1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, NY, NY, 3Education - Academic Training, Hospital for Special Surgery, NY, NY, 4Healthcare Policy and Research, Weill Cornell Medical College, NY, NY

    Background/Purpose: Tumor Necrosis Factor α inhibitors (TNFi) are widely used in patients with RA (Rheumatoid Arthritis) undergoing orthopedic surgery, yet its optimal perioperative management is…
  • Abstract Number: 2370 • 2014 ACR/ARHP Annual Meeting

    Management of Perioperative Tumor Necrosis Factor α Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis

    Susan M. Goodman1, Indu Menon2, Rie Smethurst3, Paul Christos4 and Vivian P. Bykerk1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, NY, NY, 3Education - Academic Training, Hospital for Special Surgery, NY, NY, 4Healthcare Policy and Research, Weill Cornell Medical College, NY, NY

    Background/Purpose: Tumor Necrosis Factor α inhibitors (TNFi) are widely used in patients with RA (Rheumatoid Arthritis) undergoing orthopedic surgery, yet its optimal perioperative management is…
  • Abstract Number: 1074 • 2014 ACR/ARHP Annual Meeting

    A Meta-Analysis of the Risk of Venous Thromboembolism in Inflammatory Rheumatic Diseases

    Jason J Lee1 and Janet E. Pope2, 1Medicine/Rheumatology, University of Western Ontario, London, ON, Canada, 2St Joseph Health Care, London, ON, Canada

    Background/Purpose: We performed a meta-analysis investigating the risk of developing deep vein thrombosis (DVT) and/or pulmonary embolisms (PE) in patients with inflammatory arthritis, vasculitis, and…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology